Targeted Cancer Surgery Equipment & Supplies
7 equipment items found
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
SENSEI is an advanced guidance system for minimally-invasive and robot-assisted surgical procedures, offering unprecedented intracavity maneuverability and anatomic ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
SENSEI is an advanced guidance system for minimally-invasive cancer surgery, offering unprecedented intracavity maneuverability and anatomic ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
An advanced guidance system designed for intracavity radio-guided surgery. The miniaturized SENSEI® probe enables unprecendented dexterity and anatomic reach, expanding the field of view and enabling the quick localization of radioactive hotspots. Suitable for minimally-invasive and robot-assisted surgical ...
Manufactured by:SurgiMab based inMontpellier, FRANCE
SGM-201 is a preclinical stage product based on the same technique that targets ovarian cancer. Both allow surgeons to visualize tumors in real-time with a near-infrared camera, helping them to perform more radical cytoreductive surgery, thus automatically improving surgical outcomes. ...
Manufactured by:SurgiMab based inMontpellier, FRANCE
SGM-101, currently in Phase III for the delineation of primary and recurrent tumor and metastases in patients undergoing surgery for colorectal cancer, is a tumor-specific antibody conjugated to a near-infrared fluorochrome. It selectively binds a specific marker overexpressed in gastrointestinal and other ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
Using next-generation miniaturized sensor technology, the SENSEI probe measures just over 40mm in length, enabling unprecedented intracavity maneuverability and anatomic access for surgical ...
by:Akrotome Imaging, Inc. based inCleveland, OHIO (USA)
Akrotome Molecular Probes Offer a Precisely-Targeted Intervention for Cancer Surgery. Achieving a surgical cure for cancer depends on “getting it all” – removing all diseased tissue from a patient. To meet this need, Akrotome has developed a family of quenched, substrate-based probes (qSBPs) that precisely ...